USPSTF Updates Recommendations on Testing for BRCA-related Cancers in Women

USPSTF Updates Recommendations on Testing for BRCA-related Cancers in Women
The United States Preventive Services Task Force (USPSTF) has revised their recommendations on testing for cancer-associated BRCA1/2 mutations in women, suggesting risk assessment only in those with a personal or family history of cancers associated with these mutations. These guidelines were published in the journal JAMA in a statement titled, "Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer." The genes breast cancer susceptibility 1 and 2 (BRCA1/2) provide instructions for making proteins that help cells repair damage to their DNA. Mutations in these genes that affect their function are associated with an increased risk of several types of cancer. Testing for these mutations may therefore provide insight into an individual's risk of developing these cancers. The USPSTF reviewed evidence to determine the potential benefits or harm of testing for these mutations in female patients. Monetary cost was not considered in the assessment, and the writers of the recommendation noted that "clinical decisions involve more considerations than evidence alone," so clinicians should be aware of the evidence, but make decisions based on each patient's specific situation. Based on the
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.